ReviewAnnals of medicine and surgery (2012)2025
Microgravity-induced alterations in the molecular and cellular characteristics of brain tumors: a systematic review.
Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Microgravity profoundly impacts various biological functions, including those crucial to tumorigenesis. Investigating the effects of microgravity on brain tumors is pivotal for understanding tumor biology and developing novel therapeutic strategies. This delineates the molecular and cellular characteristics of brain tumor cells under microgravity conditions. Methodology: The authors systematically reviewed the literature to identify relevant studies. Results: Microgravity has been shown to (i) induce morphological changes, where cultured glioma cells showed inhibited invasion through formation of multicellular aggregates, and ANGM5 glioblastoma multiforme (GBM) cell line showed 3D multicellular spheroid formation and loss of adhesion; (ii) inhibit cellular proliferation generally, as well as reduce invasion and migration in U87 GBM cells, however, cell viability remained high in A-172 GBM cells and human umbilical vein endothelial cells; (iii) increase DNA damage, evidenced by increased comet tail length and expression of phosphorylated γ-H2A.X, and activate apoptotic pathways in GBM and microglial cells; (iv) alter signaling pathways and protein expression through activation of ERK1/2 and AKT, altering the expression of GSK3β, Bax, and Bcl-2 in microglial and GBM cells, and through decreasing expression of vinculin and active Yap1 in GBM cells, and that of of Yap1 and ZO-1 in endothelial cells; and (v) increase chemosensitivity of GBM cells to cisplatin. Conclusion: Studies have shown that, across several rotary cell culture systems (RCCSs), random-position machines (RPMs), and 3D bioprinted GBM on-a-chip models, microgravity has consistently been proven to have profound effects on GBM cells. This further drills the potential role offered by microgravity as a promising anti-cancer agent in brain tumors, especially GBM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.